Despite extensive animal data suggesting efficacy across depression, anxiety, cognitive decline, and ADHD-relevant models, not a single human clinical trial exists for any mental health application
A Phase 2 trial (NCT01311518) was designed to test RGN-352 in ~75 heart attack patients, but was placed on FDA clinical hold in 2011 due to manufacturing (GMP) compliance issues at the contract site not safety concerns with the drug itself
Vitamin B12 injections are a simple way to support healthy red blood cell production and nerve function, which can influence mood, concentration, and calorie burn from the ground up
This excellent safety record contributed to the peptides characterization as having tolerability indistinguishable from placebo in published research
Symptoms like fatigue, tingling in hands and feet, and mood changes are non-specific and overlap with many other conditions